Dr. Atul K. Singh
Overview
Atul Singh is a Transplant Surgeon in Royal Oak, Michigan. Dr. Singh has been practicing medicine for over 33 years is highly rated in 2 conditions, according to our data. His top areas of expertise are Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), Progressive Multifocal Leukoencephalopathy, Febrile Neutropenia, and Kidney Transplant. Dr. Singh is currently accepting new patients.
His clinical research consists of co-authoring 7 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- HMO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- MEDICARE SNP
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- MEDICARE MAPD
- MEDICARE SNP
Locations
3535 West 13 Mile Road, Suites 644, Royal Oak, MI 48073
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Henry Ford Health System
Shunji Nagai is a Transplant Surgeon and a General Surgeon in Detroit, Michigan. Dr. Nagai is highly rated in 12 conditions, according to our data. His top areas of expertise are Liver Failure, Hepatitis, Neuroendocrine Tumor, Liver Transplant, and Kidney Transplant. Dr. Nagai is currently accepting new patients.
David E Lanfear MD
David Lanfear is a Cardiologist and a Transplant Surgeon in Detroit, Michigan. Dr. Lanfear has been practicing medicine for over 28 years is highly rated in 5 conditions, according to our data. His top areas of expertise are Heart Failure, Cardiomyopathy, Heart Attack, Heart Transplant, and Lung Transplant. Dr. Lanfear is currently accepting new patients.
Ascension Providence Hospital
Zane Hammoud is a Transplant Surgeon in Southfield, Michigan. Dr. Hammoud is highly rated in 16 conditions, according to our data. His top areas of expertise are Pleuropulmonary Blastoma, Lung Nodules, Lung Cancer, Endoscopy, and Gastrostomy.
Frequently Asked Questions about Dr. Atul K. Singh
How do I make an appointment with Dr. Atul K. Singh?
You can book an appointment with Dr. Atul K. Singh by calling their office at 248-551-1010. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Atul K. Singh a top-rated expert for Chronic Antibody-Mediated Rejection?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Atul K. Singh is classified as an Advanced expert for Chronic Antibody-Mediated Rejection, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Atul K. Singh specialize in?
While Dr. Atul K. Singh is a Transplant Surgery, they have specific expertise in Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), and Progressive Multifocal Leukoencephalopathy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Transplant Surgery.
Does Dr. Atul K. Singh participate in research or clinical trials?
Yes. Dr. Atul K. Singh has published 7 articles and abstracts on conditions like Chronic Antibody-Mediated Rejection. You can view a list of Dr. Atul K. Singh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Atul K. Singh accept my insurance?
Dr. Atul K. Singh accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 248-551-1010 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic Antibody-Mediated Rejection
- End-Stage Renal Disease (ESRD)Dr. Singh isAdvanced. Learn about End-Stage Renal Disease (ESRD).
- Experienced
- Febrile NeutropeniaDr. Singh isExperienced. Learn about Febrile Neutropenia.
- Kidney TransplantDr. Singh isExperienced. Learn about Kidney Transplant.
- Polycystic Kidney DiseaseDr. Singh isExperienced. Learn about Polycystic Kidney Disease.
- Progressive Multifocal Leukoencephalopathy